Arcturus Therapeutics (ARCT) Upgraded to Buy: What Does It Mean for the Stock?

Investors might want to bet on Arcturus Therapeutics (ARCT) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. The powe ...